Contents
- 1 Summary
- 2 Legal status
- 3 FAQ
- 3.1 1. What is 5-DBFPV?
- 3.2 2. How does 5-DBFPV differ from MDPV?
- 3.3 3. Is 5-DBFPV legal in Sweden?
- 3.4 4. What is the federal analogue act, and how does it relate to 5-DBFPV?
- 3.5 5. What are the effects and risks associated with 5-DBFPV use?
- 3.6 6. Is 5-DBFPV regulated in countries other than Sweden and the United States?
- 4 References
Summary
5-DBFPV, alternatively known as 5-dihydro-benzofuran pyrovalerone and 3-desoxy-MDPV, is a stimulant belonging to the cathinone class. This compound has been available for purchase online under the category of designer drugs. It serves as an analogue of MDPV, with the notable substitution of the methylenedioxyphenyl group by dihydrobenzofuran.
Identifiers | |
---|---|
IUPAC name | |
CAS Number | 2117405-32-8 hydrochloride: 2117405-33-9 |
---|---|
PubChem CID | 129844558 |
ChemSpider | 58858892 |
UNII | 260XIB9AARhydrochloride: 16K4BIO39O |
Chemical and physical data | |
Formula | C17H23NO2 |
Molar mass | 273.376 g·mol−1 |
![](https://researchem.net/wp-content/uploads/2023/10/5-DBFPV-1024x606.png)
Legal status
As of January 26, 2016, 5-DBFPV is deemed illegal in Sweden.
It’s important to note that 5-FDBFPV may potentially fall under the federal analogue act if utilized for human consumption, given its status as an analogue of Methylenedioxypyrovalerone.
FAQ
1. What is 5-DBFPV?
- 5-DBFPV, also known as 5-dihydro-benzofuran pyrovalerone and 3-deoxy-MDPV, is a stimulant drug in the cathinone class. It has been sold online as a designer drug.
2. How does 5-DBFPV differ from MDPV?
- 5-DBFPV is an analogue of MDPV, with a specific structural change where the methylenedioxyphenyl group is replaced by dihydrobenzofuran.
3. Is 5-DBFPV legal in Sweden?
- As of January 26, 2016, 5-DBFPV is illegal in Sweden.
4. What is the federal analogue act, and how does it relate to 5-DBFPV?
- The Federal Analogue Act is a U.S. federal law that allows substances substantially similar to controlled substances to be treated as controlled substances if they are intended for human consumption. In this context, 5-FDBFPV may be subject to the federal analogue act if used for human consumption due to its similarity to Methylenedioxypyrovalerone (MDPV).
5. What are the effects and risks associated with 5-DBFPV use?
- Information about the effects and risks of 5-DBFPV may vary, and research on this substance may be limited. Like any designer drug or stimulant, it may have potential health risks and side effects. It is crucial to exercise caution and seek reliable information.
6. Is 5-DBFPV regulated in countries other than Sweden and the United States?
- The legal status of 5-DBFPV can vary by country and region. It is essential to check local laws and regulations regarding its possession, sale, or use, as it may be subject to legal restrictions in different jurisdictions.
References
- “5-DBFPV” information can be found in the Cayman Chemical archives, last accessed on July 14, 2016.
- In January 2016, Kaizaki-Mitsumoto A, Noguchi N, Yamaguchi S, and colleagues conducted research identifying various drugs, including “Three 25-NBOMe-type drugs, three other phenethylamine-type drugs (25I-NBMD, RH34, and escaline), eight cathinone derivatives, and a phencyclidine analog MMXE.” This study was published in “Forensic Toxicology,” Volume 34 (1), pages 108–114, with a DOI of 10.1007/s11419-015-0293-6.
- Information on “1-(2,3-Dihydro-1-benzofuran-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one” can be found in the New Synthetic Drugs Database, last accessed on November 25, 2015.
- Details regarding “3-Desoxy-3,4-methylendioxypyrovalerone” are available through the Southern Association of Forensic Scientists, last accessed on November 25, 2015.
- In May 2017, Qian Z, Jia W, Li T, Hua Z, and Liu C explored “Identification of five pyrrolidinyl substituted cathinones.” This research focused on collision-induced dissociation and was published in “Drug Testing and Analysis,” Volume 9 (5), pages 778–787, with a DOI of 10.1002/dta.2035 and a PMID of 27367446.
- Information from “Folkhälsomyndigheten” in November 2015 indicates that “31 nya ämnen kan klassas som narkotika eller hälsofarlig vara” (31 new substances may be classified as narcotics or hazardous items). This source is in Swedish and was last accessed on July 14, 2016.